Bulletin
Investor Alert

New York Markets Close in:

Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 1:38 p.m.

/zigman2/quotes/207657083/composite

$

1.75

Change

+0.13 +7.72%

Volume

Volume 987,682

Real time quotes

/zigman2/quotes/207657083/composite

Previous close

$ 1.62

$ 1.75

Change

+0.13 +7.72%

Day low

Day high

$1.60

$1.79

Open

52 week low

52 week high

$1.47

$4.72

Open

Joshua F. Patterson

Currently, Joshua F. Patterson holds the position of Chief Compliance Officer & General Counsel at Gamida Cell Ltd.

He previously held the position of Executive Director & Deputy General Counsel at Ionis Pharmaceuticals, Inc. and General Counsel for Akcea Therapeutics, Inc. (a subsidiary of Ionis Pharmaceuticals, Inc.) and In-House Counsel at Amylin Pharmaceuticals, Inc.

Mr. Patterson received an undergraduate degree from Carthage College and a graduate degree from Syracuse University.

Transactions

Date Shares Transaction Value
01/28/2022 51,000   Award at $0 per share. 0

Officers and Executives

Mr. Robert I. Blum
Chairman
Dr. Julian Adams
Chief Executive Officer & Director
Mr. Michele I. Korfin
Chief Operating & Commercial Officer
Mr. Shai Lankry
Chief Financial Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Tzvi Palash
Chief Manufacturing Officer
Dr. Anat Cohen-Dayag
Director
Dr. Naama Halevi-Davidov
Director
Dr. Ivan M. Borrello
Director
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Chief of Staff
Dr. Jas Uppal
Chief Regulatory & Quality Officer
Ms. Shawn Cline Tomasello
Independent Director
Mr. Stephen T. Wills
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.